Morgan Stanley resumed coverage of Illumina (ILMN) with an Equal Weight rating and $156 price target While the firm views the move higher as “justified” after GRAIL resolution, framing achievable long-term targets and an efficiency push, it sees the stock as range-bound pending evidence of a sustained top-line reacceleration, the analyst tells investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target raised to $184 from $170 at Stephens
- Illumina price target lowered to $185 from $195 at Piper Sandler
- Illumina price target raised to $139 from $124 at Baird
- Illumina price target raised to $254 from $252 at RBC Capital
- Illumina price target raised to $177 from $166 at TD Cowen